High Rates of Prostate-specific Antigen Testing in Men with Evidence of Benign Prostatic Hyperplasia
- 30 June 1998
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (6) , 517-525
- https://doi.org/10.1016/s0002-9343(98)00113-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interpreting results of prostate-specific antigen testing for early detection of prostate cancerJournal of General Internal Medicine, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the EvidenceNew England Journal of Medicine, 1995
- What is the ‘normal range’ for prostate‐specific antigen? Use of a receiver operating characteristic curve to evaluate a serum markerBritish Journal of Urology, 1995
- Prostate Specific Antigen Cannot Distinguish Stage T1a (A1) Prostate Cancer from Benign Prostatic HyperplasiaJournal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Serum Prostate-Specific Antigen Discriminates Weakly between Men with Benign Prostatic Hyperplasia and Patients with Organ-Confined Prostate CancerEuropean Urology, 1994
- Risk Factors for Prostate CancerAnnals of Internal Medicine, 1993
- The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 menCancer, 1991
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991